Gates Medical Research Institute
18
3
4
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 80/100
27.8%
5 terminated/withdrawn out of 18 trials
64.3%
-22.2% vs industry average
11%
2 trials in Phase 3/4
67%
6 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (18)
Bactericidal Activity of TBD09 in Combination With Other Drugs in Pulmonary Tuberculosis
Role: lead
Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults
Role: lead
Bactericidal Activity and Safety of Nicotinamide in Combination With Bedaquiline, Pretomanid, and Linezolid in Drug-susceptible Pulmonary Tuberculosis
Role: lead
A Trial in Healthy Adult Participants to Evaluate the Safety, Tolerability, and Behavior in the Body of TBD11
Role: lead
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBD09
Role: lead
Study To Evaluate Safety, Tolerability, and Pharmacokinetics of MAM01 in African Population
Role: lead
Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine M72/AS01E in Participants With Well-controlled HIV
Role: lead
Bacille Calmette Guerin (BCG) Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection
Role: lead
Impact of Bi-26 Supplementation on Weight Gain in Underweight Infants
Role: lead
Efficacy and Safety Evaluation of Two to Four Months of Treatment With the Combination Regimens of DBOS and PBOS in Adults With Pulmonary Tuberculosis
Role: lead
Safety, Tolerability, Pharmacokinetics and Protective Efficacy of MAM01 in Healthy Adults
Role: lead
Epidemiologic Study to Assess the IGRA Positivity in Populations With a High TB Burden
Role: lead
Safety, Tolerability, Pharmacokinetics (PK), and Food Effect of MK-7762 in Healthy Adults
Role: lead
Safety, Tolerability, and Pharmacokinetics of RSV Monoclonal Antibody RSM01 in Healthy Adults
Role: lead
A Study to Investigate the Safety and Immunogenicity of the SF2a-TT15 Synthetic Carbohydrate-based Conjugate Vaccine Against Shigella Flexneri 2a
Role: collaborator
Early Bactericidal Activity of TBA-7371 in Pulmonary Tuberculosis
Role: lead
Proof of Concept Trial of Adjuvant Activity of SWE, a Squalene-based -Oil-in-water Emulsion
Role: lead
A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19)
Role: lead
All 18 trials loaded